179 related articles for article (PubMed ID: 14998744)
1. Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure.
Stangle DE; Strawderman MS; Smith D; Kuypers M; Strupp BJ
Environ Health Perspect; 2004 Mar; 112(3):302-8. PubMed ID: 14998744
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
3. The scientific basis for chelation: animal studies and lead chelation.
Smith D; Strupp BJ
J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
5. Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.
Stangle DE; Smith DR; Beaudin SA; Strawderman MS; Levitsky DA; Strupp BJ
Environ Health Perspect; 2007 Feb; 115(2):201-9. PubMed ID: 17384765
[TBL] [Abstract][Full Text] [Related]
6. Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats.
Beaudin SA; Stangle DE; Smith DR; Levitsky DA; Strupp BJ
Neurotoxicol Teratol; 2007; 29(2):188-202. PubMed ID: 17196787
[TBL] [Abstract][Full Text] [Related]
7. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
8. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
[TBL] [Abstract][Full Text] [Related]
9. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
10. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
[TBL] [Abstract][Full Text] [Related]
11. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
[TBL] [Abstract][Full Text] [Related]
12. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
[TBL] [Abstract][Full Text] [Related]
13. The effects of succimer chelation therapy on auditory function in rhesus monkeys.
Lasky RE; Luck ML; Laughlin NK
Neurotoxicol Teratol; 2001; 23(6):651-8. PubMed ID: 11792533
[TBL] [Abstract][Full Text] [Related]
14. Succimer chelation does not produce lasting reductions of blood lead levels in a rodent model of retained lead fragments.
Twardy SM; Hanson SM; Jursa T; Gaitens JM; Kalinich JM; McDiarmid MA; Smith DR
Environ Toxicol Pharmacol; 2023 Nov; 104():104283. PubMed ID: 37775076
[TBL] [Abstract][Full Text] [Related]
15. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
16. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats.
Zhang Y; Zhou L; Li S; Liu J; Sun S; Ji X; Yan C; Xu J
Ecotoxicol Environ Saf; 2019 Nov; 183():109441. PubMed ID: 31404725
[TBL] [Abstract][Full Text] [Related]
17. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
18. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
19. Succimer for treatment of lead toxicosis in two cats.
Knight TE; Kent M; Junk JE
J Am Vet Med Assoc; 2001 Jun; 218(12):1946-8, 1936. PubMed ID: 11417739
[TBL] [Abstract][Full Text] [Related]
20. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
